Home > Insider Trading > Filing (0000908662-13-000264)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
907562	Dyax Corp	DYAX	Services-Commercial Physical & Biological Research (8731)	043053198

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1573163	D. Andrew Ashe	C/O Dyax Corp. 55 Network Drive Burlington MA 01803-2756	General Counsel & Sr. Vp, Adm.	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-08-13	8,000	$2.06	23,000	No	4	M	Direct
Common Stock	Acquisiton	2013-08-13	2,000	$1.87	25,000	No	4	M	Direct
Common Stock	Acquisiton	2013-08-13	10,625	$1.48	35,625	No	4	M	Direct
Common Stock	Acquisiton	2013-08-13	11,875	$1.41	47,500	No	4	M	Direct
Common Stock	Disposition	2013-08-13	32,500	$4.30	15,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2013-08-13	8,000	$0.00	8,000	$2.06
Common Stock	Stock Option (right to buy)	Disposition	2013-08-13	2,000	$0.00	2,000	$1.87
Common Stock	Stock Option (right to buy)	Disposition	2013-08-13	10,625	$0.00	10,625	$1.48
Common Stock	Stock Option (right to buy)	Disposition	2013-08-13	11,875	$0.00	11,875	$1.41

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
62,320	2022-06-20	No	4	M	Direct
11,200	2021-02-10	No	4	M	Direct
86,875	2022-02-24	No	4	M	Direct
18,125	2022-01-03	No	4	M	Direct

Footnotes

Such option becomes exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant (with any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding monthly period in which a whole share equivalent is accumulated). The grant date was June 20, 2012.
Such option becomes exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant (with any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding monthly period in which a whole share equivalent is accumulated). The grant date was February 10, 2011.
Such option becomes exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant (with any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding monthly period in which a whole share equivalent is accumulated). The grant date was February 24, 2012.
Such option becomes exercisable in forty-eight (48) substantially equal installments at the end of each monthly anniversary of the date of grant (with any fractional shares to be cumulated and to become exercisable at the end of the earliest succeeding monthly period in which a whole share equivalent is accumulated). The grant date was January 3, 2012.